Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arvinas, Inc. (ARVN) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arvinas, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1655759.
Total stock buying since 2018: $69,124,438.
Total stock sales since 2018: $159,870,587.
Total stock option exercises since 2018: $10,595,401.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 62,720 | $899,435 | 0 | $0 |
| 2024 | 0 | $0 | 10,529 | $490,915 | 8,252 | $132,032 |
| 2023 | 0 | $0 | 10,227 | $292,334 | 28,996 | $0 |
| 2022 | 0 | $0 | 86,664 | $5,934,667 | 99,874 | $1,201,216 |
| 2021 | 0 | $0 | 1,489,164 | $121,364,781 | 436,290 | $8,026,738 |
| 2020 | 161,190 | $10,552,767 | 69,001 | $2,944,577 | 80,105 | $935,415 |
| 2019 | 684,500 | $15,026,071 | 1,413,074 | $27,943,878 | 18,750 | $300,000 |
| 2018 | 2,721,600 | $43,545,600 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 8,283 | $62,723 | 0 | $0 |
| 2025-03 | 0 | $0 | 8,658 | $74,372 | 0 | $0 |
| 2025-02 | 0 | $0 | 45,779 | $762,340 | 0 | $0 |
| 2024-11 | 0 | $0 | 231 | $6,396 | 0 | $0 |
| 2024-02 | 0 | $0 | 10,298 | $484,519 | 0 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 8,252 | $132,032 |
| 2023-11 | 0 | $0 | 229 | $3,904 | 0 | $0 |
| 2023-08 | 0 | $0 | 1,324 | $32,288 | 4,010 | $0 |
| 2023-03 | 0 | $0 | 8,674 | $256,142 | 24,986 | $0 |
| 2022-08 | 0 | $0 | 1,258 | $86,794 | 4,010 | $0 |
| 2022-04 | 0 | $0 | 20,960 | $1,385,749 | 16,188 | $259,008 |
| 2022-03 | 0 | $0 | 23,486 | $1,592,593 | 43,488 | $296,000 |
| 2022-02 | 0 | $0 | 20,000 | $1,483,300 | 20,000 | $387,200 |
| 2022-01 | 0 | $0 | 20,960 | $1,386,231 | 16,188 | $259,008 |
| 2021-12 | 0 | $0 | 390,705 | $26,362,659 | 35,000 | $979,599 |
| 2021-11 | 0 | $0 | 366,389 | $32,668,536 | 78,423 | $1,506,035 |
| 2021-09 | 0 | $0 | 200,000 | $17,413,629 | 4,690 | $75,040 |
| 2021-08 | 0 | $0 | 308,053 | $27,146,189 | 69,933 | $1,054,752 |
| 2021-07 | 0 | $0 | 17,242 | $1,724,200 | 17,242 | $275,872 |
| 2021-06 | 0 | $0 | 64,586 | $5,169,947 | 64,586 | $1,660,976 |
| 2021-04 | 0 | $0 | 25,000 | $1,669,750 | 25,000 | $400,000 |
| 2021-03 | 0 | $0 | 11,230 | $869,762 | 24,987 | $0 |
| 2021-02 | 0 | $0 | 105,959 | $8,340,109 | 116,429 | $2,074,464 |
| 2020-12 | 142,857 | $9,999,990 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-24 | Saik Andrew (Chief Financial Officer) | Sale | 5,700 | 7.61 | 43,377 |
| 2025-06-17 | Cacace Angela M (Chief Scientific Officer) | Sale | 2,583 | 7.49 | 19,346 |
| 2025-03-18 | Berkowitz Noah (Chief Medical Officer) | Sale | 8,658 | 8.59 | 74,372 |
| 2025-02-24 | Cacace Angela M (Chief Scientific Officer) | Sale | 4,207 | 16.65 | 70,046 |
| 2025-02-24 | Loomis David K (Chief Accounting Officer) | Sale | 1,214 | 16.75 | 20,334 |
| 2025-02-24 | Houston John G (President and CEO) | Sale | 31,338 | 16.65 | 521,777 |
| 2025-02-24 | Taylor Ian (President, R&D) | Sale | 9,020 | 16.65 | 150,183 |
| 2024-11-07 | Loomis David K (Chief Accounting Officer) | Sale | 231 | 27.69 | 6,396 |
| 2024-02-23 | Peck Ronald (Chief Medical Officer) | Sale | 1,699 | 47.05 | 79,937 |
| 2024-02-23 | Houston John G (President and CEO) | Sale | 5,196 | 47.05 | 244,471 |
| 2024-02-23 | Taylor Ian (Chief Scientific Officer) | Sale | 1,701 | 47.05 | 80,032 |
| 2024-02-23 | Cassidy Sean A (Chief Financial Officer) | Sale | 1,702 | 47.05 | 80,079 |
| 2024-01-04 | Taylor Ian (Chief Scientific Officer) | Option Ex | 8,252 | 16.00 | 132,032 |
| 2023-11-08 | Loomis David K (Chief Accounting Officer) | Sale | 229 | 17.05 | 3,904 |
| 2023-08-11 | Peck Ronald (Chief Medical Officer) | Sale | 1,324 | 24.39 | 32,288 |
| 2023-08-11 | Peck Ronald (Chief Medical Officer) | Option Ex | 4,010 | .00 | 0 |
| 2023-03-01 | Houston John G (President and CEO) | Sale | 5,878 | 29.53 | 173,577 |
| 2023-03-01 | Houston John G (President and CEO) | Option Ex | 17,510 | .00 | 0 |
| 2023-03-01 | Taylor Ian (Chief Scientific Officer) | Sale | 1,051 | 29.53 | 31,036 |
| 2023-03-01 | Taylor Ian (Chief Scientific Officer) | Option Ex | 2,685 | .00 | 0 |
| 2023-03-01 | Cassidy Sean A (Chief Financial Officer) | Sale | 1,745 | 29.53 | 51,529 |
| 2023-03-01 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 4,791 | .00 | 0 |
| 2022-08-12 | Peck Ronald (Chief Medical Officer) | Sale | 1,258 | 68.99 | 86,794 |
| 2022-08-12 | Peck Ronald (Chief Medical Officer) | Option Ex | 4,010 | .00 | 0 |
| 2022-04-14 | Morrison Briggs (Director) | Sale | 20,960 | 66.11 | 1,385,749 |
| 2022-04-14 | Morrison Briggs (Director) | Option Ex | 16,188 | 16.00 | 259,008 |
| 2022-03-11 | Cassidy Sean A (Chief Financial Officer) | Sale | 15,000 | 70.00 | 1,050,000 |
| 2022-03-11 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 15,000 | 16.00 | 240,000 |
| 2022-03-04 | Houston John G (President and CEO) | Sale | 6,024 | 63.94 | 385,174 |
| 2022-03-04 | Houston John G (President and CEO) | Option Ex | 17,511 | .00 | 0 |
| 2022-03-04 | Taylor Ian (Chief Scientific Officer) | Sale | 869 | 63.94 | 55,563 |
| 2022-03-04 | Taylor Ian (Chief Scientific Officer) | Option Ex | 2,686 | .00 | 0 |
| 2022-03-04 | Cassidy Sean A (Chief Financial Officer) | Sale | 1,593 | 63.94 | 101,856 |
| 2022-03-04 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 4,791 | .00 | 0 |
| 2022-03-01 | Taylor Ian (Chief Scientific Officer) | Option Ex | 3,500 | 16.00 | 56,000 |
| 2022-02-15 | Taylor Ian (Chief Scientific Officer) | Sale | 20,000 | 74.17 | 1,483,300 |
| 2022-02-15 | Taylor Ian (Chief Scientific Officer) | Option Ex | 20,000 | 19.36 | 387,200 |
| 2022-01-14 | Morrison Briggs (Director) | Sale | 20,960 | 66.14 | 1,386,231 |
| 2022-01-14 | Morrison Briggs (Director) | Option Ex | 16,188 | 16.00 | 259,008 |
| 2021-12-30 | Peck Ronald (Chief Medical Officer) | Sale | 20,000 | 80.66 | 1,613,100 |
| 2021-12-30 | Peck Ronald (Chief Medical Officer) | Option Ex | 20,000 | 36.98 | 739,599 |
| 2021-12-17 | Cassidy Sean A (Chief Financial Officer) | Sale | 15,000 | 70.00 | 1,050,000 |
| 2021-12-17 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 15,000 | 16.00 | 240,000 |
| 2021-12-16 | Ratcliffe Liam (Director) | Sale | 85,705 | 69.31 | 5,940,556 |
| 2021-12-15 | Ratcliffe Liam (Director) | Sale | 113,536 | 66.57 | 7,557,864 |
| 2021-12-14 | Ratcliffe Liam (Director) | Sale | 156,464 | 65.20 | 10,201,139 |
| 2021-11-15 | Taylor Ian (Chief Scientific Officer) | Sale | 20,000 | 84.06 | 1,681,100 |
| 2021-11-15 | Taylor Ian (Chief Scientific Officer) | Option Ex | 20,000 | 17.68 | 353,600 |
| 2021-11-15 | Ratcliffe Liam (Director) | Sale | 21,284 | 84.49 | 1,798,200 |
| 2021-11-12 | Ratcliffe Liam (Director) | Sale | 39,869 | 84.76 | 3,379,455 |
| 2021-11-11 | Ratcliffe Liam (Director) | Sale | 59,799 | 86.67 | 5,182,898 |
| 2021-11-10 | Ratcliffe Liam (Director) | Sale | 13,358 | 88.23 | 1,178,603 |
| 2021-11-09 | Ratcliffe Liam (Director) | Sale | 33,008 | 91.97 | 3,035,646 |
| 2021-11-08 | Ratcliffe Liam (Director) | Sale | 81,054 | 93.66 | 7,591,517 |
| 2021-11-05 | Ratcliffe Liam (Director) | Sale | 58,017 | 91.38 | 5,301,477 |
| 2021-11-05 | Ratcliffe Liam (Director) | Option Ex | 18,423 | 27.82 | 512,435 |
| 2021-11-01 | Houston John G (President and CEO) | Sale | 40,000 | 87.99 | 3,519,640 |
| 2021-11-01 | Houston John G (President and CEO) | Option Ex | 40,000 | 16.00 | 640,000 |
| 2021-09-07 | Shannon Timothy M (Director) | Sale | 36,411 | 89.43 | 3,256,090 |
| 2021-09-03 | Shannon Timothy M (Director) | Sale | 32,387 | 85.93 | 2,783,014 |
| 2021-09-02 | Houston John G (President and CEO) | Option Ex | 4,690 | 16.00 | 75,040 |
| 2021-09-02 | Shannon Timothy M (Director) | Sale | 51,765 | 85.88 | 4,445,474 |
| 2021-09-01 | Shannon Timothy M (Director) | Sale | 79,437 | 87.23 | 6,929,051 |
| 2021-08-31 | Shannon Timothy M (Director) | Sale | 59,355 | 85.80 | 5,092,659 |
| 2021-08-30 | Shannon Timothy M (Director) | Sale | 58,838 | 86.83 | 5,108,962 |
| 2021-08-27 | Shannon Timothy M (Director) | Sale | 45,026 | 85.72 | 3,859,538 |
| 2021-08-26 | Margus Bradley Albert (Director) | Sale | 9,940 | 85.03 | 845,168 |
| 2021-08-26 | Shannon Timothy M (Director) | Sale | 11,712 | 85.12 | 996,972 |
| 2021-08-25 | Margus Bradley Albert (Director) | Sale | 20,000 | 85.00 | 1,700,000 |
| 2021-08-25 | Shannon Timothy M (Director) | Sale | 14,267 | 85.03 | 1,213,151 |
| 2021-08-24 | Shannon Timothy M (Director) | Sale | 9,203 | 87.02 | 800,817 |
| 2021-08-23 | Shannon Timothy M (Director) | Sale | 1,599 | 88.01 | 140,727 |
| 2021-08-16 | Taylor Ian (Chief Scientific Officer) | Sale | 20,000 | 87.60 | 1,751,940 |
| 2021-08-16 | Taylor Ian (Chief Scientific Officer) | Option Ex | 20,000 | 16.00 | 320,000 |
| 2021-08-13 | Margus Bradley Albert (Director) | Sale | 5,828 | 90.03 | 524,694 |
| 2021-08-12 | Peck Ronald (Chief Medical Officer) | Sale | 1,363 | 90.53 | 123,399 |
| 2021-08-12 | Peck Ronald (Chief Medical Officer) | Option Ex | 4,011 | .00 | 0 |
| 2021-08-11 | Margus Bradley Albert (Director) | Sale | 5,000 | 90.03 | 450,150 |
| 2021-08-02 | Houston John G (President and CEO) | Sale | 45,922 | 98.82 | 4,538,012 |
| 2021-08-02 | Houston John G (President and CEO) | Option Ex | 45,922 | 16.00 | 734,752 |
| 2021-07-28 | Cassidy Sean A (Chief Financial Officer) | Sale | 17,242 | 100.00 | 1,724,200 |
| 2021-07-28 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 17,242 | 16.00 | 275,872 |
| 2021-06-30 | Peck Ronald (Chief Medical Officer) | Sale | 20,000 | 76.69 | 1,533,800 |
| 2021-06-30 | Peck Ronald (Chief Medical Officer) | Option Ex | 20,000 | 47.38 | 947,600 |
| 2021-06-10 | Houston John G (President and CEO) | Sale | 43,886 | 81.58 | 3,580,044 |
| 2021-06-10 | Houston John G (President and CEO) | Option Ex | 43,886 | 16.00 | 702,176 |
| 2021-06-09 | Houston John G (President and CEO) | Sale | 700 | 80.15 | 56,103 |
| 2021-06-09 | Houston John G (President and CEO) | Option Ex | 700 | 16.00 | 11,200 |
| 2021-04-05 | Taylor Ian (Chief Scientific Officer) | Sale | 25,000 | 66.79 | 1,669,750 |
| 2021-04-05 | Taylor Ian (Chief Scientific Officer) | Option Ex | 25,000 | 16.00 | 400,000 |
| 2021-03-02 | Houston John G (President and CEO) | Sale | 8,115 | 77.45 | 628,506 |
| 2021-03-02 | Houston John G (President and CEO) | Option Ex | 17,510 | .00 | 0 |
| 2021-03-02 | Taylor Ian (Chief Scientific Officer) | Sale | 894 | 77.45 | 69,240 |
| 2021-03-02 | Taylor Ian (Chief Scientific Officer) | Option Ex | 2,685 | .00 | 0 |
| 2021-03-02 | Cassidy Sean A (Chief Financial Officer) | Sale | 2,221 | 77.45 | 172,016 |
| 2021-03-02 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 4,792 | .00 | 0 |
| 2021-02-19 | Taylor Ian (Chief Scientific Officer) | Option Ex | 6,456 | 16.00 | 103,296 |
| 2021-02-17 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 894 | 16.00 | 14,304 |
| 2021-02-16 | Peck Ronald (Chief Medical Officer) | Sale | 20,000 | 77.35 | 1,547,000 |
| 2021-02-16 | Peck Ronald (Chief Medical Officer) | Option Ex | 20,000 | 26.58 | 531,600 |
| 2021-02-16 | Houston John G (President and CEO) | Sale | 44,000 | 79.06 | 3,478,684 |
| 2021-02-16 | Houston John G (President and CEO) | Option Ex | 45,560 | 16.00 | 728,960 |
| 2021-02-16 | Cassidy Sean A (Chief Financial Officer) | Sale | 41,959 | 78.99 | 3,314,425 |
| 2021-02-16 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 41,959 | 16.00 | 671,344 |
| 2020-12-18 | Ratcliffe Liam (Director) | Buy | 142,857 | 70.00 | 9,999,990 |
| 2020-11-09 | Kennedy Edward Moore Jr. (Director) | Buy | 8,333 | 23.99 | 199,908 |
| 2020-11-09 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 3,006 | 16.00 | 48,096 |
| 2020-08-14 | Peck Ronald (Chief Medical Officer) | Sale | 1,256 | 27.46 | 34,489 |
| 2020-08-14 | Peck Ronald (Chief Medical Officer) | Option Ex | 4,010 | .00 | 0 |
| 2020-06-17 | Shannon Timothy M (Director) | Buy | 2,000 | 30.26 | 60,520 |
| 2020-06-02 | Shannon Timothy M (Director) | Buy | 3,000 | 32.30 | 96,899 |
| 2020-05-26 | Ratcliffe Liam (Director) | Option Ex | 6,500 | 22.06 | 143,390 |
| 2020-05-26 | Shannon Timothy M (Director) | Option Ex | 12,923 | 22.06 | 285,081 |
| 2020-05-13 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 1,356 | 16.00 | 21,696 |
| 2020-05-12 | Cassidy Sean A (Chief Financial Officer) | Sale | 10,000 | 60.00 | 600,000 |
| 2020-03-24 | Morrison Briggs (Director) | Buy | 2,500 | 38.18 | 95,450 |
| 2020-03-23 | Houston John G (President and CEO) | Option Ex | 6,250 | 16.00 | 100,000 |
| 2020-03-23 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 8,030 | 16.00 | 128,480 |
| 2020-03-20 | Shannon Timothy M (Director) | Buy | 2,500 | 40.00 | 100,000 |
| 2020-03-19 | Houston John G (President and CEO) | Sale | 5,405 | 37.61 | 203,282 |
| 2020-03-19 | Houston John G (President and CEO) | Option Ex | 17,511 | .00 | 0 |
| 2020-03-19 | Taylor Ian (Chief Scientific Officer) | Sale | 826 | 37.61 | 31,065 |
| 2020-03-19 | Taylor Ian (Chief Scientific Officer) | Option Ex | 2,686 | .00 | 0 |
| 2020-03-19 | Cassidy Sean A (Chief Financial Officer) | Sale | 1,514 | 37.61 | 56,941 |
| 2020-03-19 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 4,791 | .00 | 0 |
| 2020-03-18 | Margus Bradley Albert (Director) | Sale | 40,000 | 37.46 | 1,498,400 |
| 2020-02-07 | Cassidy Sean A (Chief Financial Officer) | Sale | 10,000 | 52.04 | 520,400 |
| 2020-01-28 | Taylor Ian (Chief Scientific Officer) | Option Ex | 13,042 | 16.00 | 208,672 |
| 2019-12-17 | Houston John G (President and CEO) | Option Ex | 12,500 | 16.00 | 200,000 |
| 2019-11-19 | Cassidy Sean A (Chief Financial Officer) | Sale | 10,000 | 32.00 | 320,000 |
| 2019-11-13 | Taylor Ian (Chief Scientific Officer) | Sale | 10,000 | 28.00 | 280,000 |
| 2019-11-12 | Ratcliffe Liam (Director) | Buy | 680,000 | 22.00 | 14,960,000 |
| 2019-11-05 | Taylor Ian (Chief Scientific Officer) | Sale | 10,000 | 23.80 | 238,000 |
| 2019-09-30 | Taylor Ian (Chief Scientific Officer) | Sale | 10,000 | 22.15 | 221,500 |
| 2019-08-07 | Cassidy Sean A (Chief Financial Officer) | Option Ex | 6,250 | 16.00 | 100,000 |
| 2019-07-29 | Cassidy Sean A (Chief Financial Officer) | Sale | 11,945 | 27.07 | 323,315 |
| 2019-06-28 | Schwab Andrew J. (10% Owner) | Sale | 360,000 | 22.02 | 7,927,200 |
| 2019-06-27 | Schwab Andrew J. (10% Owner) | Sale | 450,000 | 21.75 | 9,787,500 |
| 2019-06-07 | Schwab Andrew J. (10% Owner) | Sale | 190,000 | 19.65 | 3,733,499 |
| 2019-03-29 | Taylor Ian (Chief Scientific Officer) | Buy | 1,000 | 14.66 | 14,660 |
| 2019-03-28 | Schwab Andrew J. (10% Owner) | Sale | 361,129 | 14.16 | 5,112,864 |
| 2019-03-28 | Shannon Timothy M (Director) | Buy | 3,500 | 14.69 | 51,411 |
| 2018-10-01 | Kennedy Edward Moore Jr. (Director) | Buy | 21,000 | 16.00 | 336,000 |
| 2018-10-01 | Loven Jakob (Director) | Buy | 312,500 | 16.00 | 5,000,000 |
| 2018-10-01 | Houston John G (President and CEO) | Buy | 30,000 | 16.00 | 480,000 |
| 2018-10-01 | Margus Bradley Albert (Director) | Buy | 40,000 | 16.00 | 640,000 |
| 2018-10-01 | Deerfield Private Design Fund Iv, L.p. | Buy | 312,500 | 16.00 | 5,000,000 |
| 2018-10-01 | Ratcliffe Liam (Director) | Buy | 1,000,000 | 16.00 | 16,000,000 |
| 2018-10-01 | Cassidy Sean A (Chief Financial Officer) | Buy | 1,600 | 16.00 | 25,600 |
| 2018-10-01 | Kolchinsky Peter | Buy | 1,000,000 | 16.00 | 16,000,000 |
| 2018-10-01 | Shannon Timothy M (Director) | Buy | 4,000 | 16.00 | 64,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arvinas, Inc. (symbol ARVN, CIK number 1655759) see the Securities and Exchange Commission (SEC) website.